Treatment of Persistent Cough in Subjects with Idiopathic Pulmonary Fibrosis (IPF) with Gefapixant, a P2X3 Antagonist, in a Randomized, Placebo-Controlled Clinical Trial
media
posted on 2021-05-26, 10:56 authored by Adis journals on behalf of, Fernando J. Martinez, Amna Sadaf Afzal, Jaclyn A. Smith, Anthony P. Ford, Jerry Jing Li, Yuping Li, Michael KittelbergerArticle full text
The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.
